2024

1. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

   Enfermedades Infecciosas y Microbiologia Clinica

2. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

   Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

3. Aspergillus granulosus femoral osteomyelitis in a cardiac transplant patient: first reported case and literature review

   Therapeutic Advances in Infectious Disease, Vol. 11

4. Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study

   Frontiers in Public Health, Vol. 12

5. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

   Infectious Diseases, Vol. 56, Núm. 6, pp. 441-450

6. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

   European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

7. Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care

   Journal of Clinical Medicine, Vol. 13, Núm. 2

8. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

9. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

   mSphere, Vol. 9, Núm. 3

10. Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic

    Mycoses, Vol. 67, Núm. 1

11. Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human

    Vascular Pharmacology, Vol. 155

12. Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities

    Archivos de Bronconeumologia

13. Corrigendum: Tranexamic acid in combination with vancomycin or gentamicin has a synergistic effect against staphylococci (Front. Microbiol., (2023), 13, 935646, 10.3389/fmicb.2022.935646)

    Frontiers in Microbiology

14. Current challenges in acute bacterial skin infection management

    Current opinion in infectious diseases, Vol. 37, Núm. 2, pp. 71-79

15. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

16. Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD) in Primary Care

    Open Respiratory Archives

17. Economic Burden of Clostridioides difficile Infection in European Countries

    Advances in experimental medicine and biology, Vol. 1435, pp. 1-12

18. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

19. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

20. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3